![ECOG-ACRIN logo[19516]275×75](https://blog.ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
April 15, 2022
Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
February 24, 2022
The first published results of a platform trial of PIK3CA mutations across multiple tumor types appear in the Journal of Clinical Oncology. The data are from the NCI-MATCH precision medicine trial.
December 22, 2021
The co-chairs reflect on key 2021 accomplishments, and share their thanks and best wishes for a happy New Year
October 19, 2021
Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
September 30, 2021
Removing one of several steps will help speed the process for identifying patients who may be eligible to enroll for treatment in NCI-MATCH
September 30, 2021
Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
July 7, 2021
Recent ECOG-ACRIN trial updates and results
April 27, 2021
In this interview, Dr. Peter O'Dwyer urges physicians, sites, and testing laboratories to redouble efforts to locate patients for 12 open arms
October 19, 2020
